Laurus Labs reported a strong June-quarter performance, with net profit more than doubling and revenue rising 29% year-on-year, driven by robust growth in its CDMO business and affordable medicines portfolio. The company also reported margin expansion, reaffirmed its capex plans, and continued to attract higher institutional interest, boosting investor sentiment.
Only 2 of 23 mutual fund themes gained in August; IPO, defence stay green as auto, railways and tech slide : Report
Only two of 23 mutual fund themes, IPO and defence, gained in August as domestic equities faced broad-based pressure, according to Vallum Capital. Auto, railways